possible link between atypical antipsychotics and diabetes
November 2003
You'll see more attention focused on the possible link between atypical antipsychotics and diabetes.
FDA and drug companies will battle out new labeling requirements for warnings about diabetes risks in patients taking atypicals.
The FDA wants the warnings to apply to ALL atypicals. But some companies don't think their drug needs the new warning at all.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote